drugset / Trial / NCT02230930

Treatment of Apomorphine-induced Skin Reactions: a Pilot Study

NCT02230930

Phase 2 Terminated 13 enrolled University Medical Center Groningen
Non-randomizedCrossoverOpen-labelTreatment

Summary

Skin reactions as a result of continuous subcutaneous apomorphine infusion occur frequently and interfere with the absorption of apomorphine. The histopathology of apomorphine-induced skin reactions is poorly understood. Therefore treatment options are limited and suggestive. Objective: to investigate the efficacy of four treatments including massage, dilution of apomorphine, treatment with topical hydrocortisone and pre-treatment with subcutaneous administered hydrocortisone, in Parkinson's disease patients with apomorphine-induced skin reactions.

Timeline

Start
2015-06
Primary completion
2018-12-31
Completion
2018-12-31

Drugs

EvaluationDrugModalityDoseRoute
Comparator Apomorphine Unknown 0.25 % Subcutaneous
Comparator Hydrocortisone Other / unclassified 1 % Topical
Comparator Hydrocortisone Other / unclassified 10 mg Topical

Indications